Novo Integrated Sciences, Inc. Quarterly Cost of Revenue in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Novo Integrated Sciences, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2016 to Q2 2024.
  • Novo Integrated Sciences, Inc. Cost of Revenue for the quarter ending May 31, 2024 was $2.25M, a 14% increase year-over-year.
  • Novo Integrated Sciences, Inc. Cost of Revenue for the twelve months ending May 31, 2024 was $8.42M.
  • Novo Integrated Sciences, Inc. annual Cost of Revenue for 2023 was $7.62M, a 9.81% increase from 2022.
  • Novo Integrated Sciences, Inc. annual Cost of Revenue for 2022 was $6.94M, a 26.6% increase from 2021.
  • Novo Integrated Sciences, Inc. annual Cost of Revenue for 2021 was $5.48M, a 14.2% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.42M $2.25M +$276K +14% Mar 1, 2024 May 31, 2024 10-Q 2024-07-19
Q1 2024 $8.15M $1.85M +$261K +16.5% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $7.89M $1.95M +$267K +15.9% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-22
Q3 2023 $7.62M $2.38M +$10.4M Jun 1, 2023 Aug 31, 2023 10-K 2023-12-14
Q2 2023 -$2.81M $1.98M -$9.46M -82.7% Mar 1, 2023 May 31, 2023 10-Q 2024-07-19
Q1 2023 $6.66M $1.59M -$67.3K -4.07% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 $6.72M $1.68M -$216K -11.4% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-22
Q3 2022 $6.94M -$8.05M -$9.77M -570% Jun 1, 2022 Aug 31, 2022 10-K 2023-12-14
Q2 2022 $16.7M $11.4M +$10.3M +940% Mar 1, 2022 May 31, 2022 10-Q 2023-07-17
Q1 2022 $6.36M $1.65M +$328K +24.8% Dec 1, 2021 Feb 28, 2022 10-Q 2023-05-26
Q4 2021 $6.03M $1.9M +$551K +41% Sep 1, 2021 Nov 30, 2021 10-Q 2023-05-24
Q3 2021 $5.48M $1.71M +$690K +67.4% Jun 1, 2021 Aug 31, 2021 10-K 2023-04-03
Q2 2021 $4.79M $1.1M +$541K +96.5% Mar 1, 2021 May 31, 2021 10-Q 2022-07-14
Q1 2021 $4.25M $1.32M -$261K -16.5% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-13
Q4 2020 $4.51M $1.34M -$289K -17.7% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-18
Q3 2020 $4.8M $1.02M -$573K -35.9% Jun 1, 2020 Aug 31, 2020 10-K 2021-12-14
Q2 2020 $5.38M $560K -$997K -64% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 $6.37M $1.59M +$265K +20.1% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 $6.11M $1.63M +$205K +14.3% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-13
Q3 2019 $5.9M $1.6M +$259K +19.3% Jun 1, 2019 Aug 31, 2019 10-K 2020-12-09
Q2 2019 $5.64M $1.56M +$139K +9.79% Mar 1, 2019 May 31, 2019 10-Q 2020-07-14
Q1 2019 $5.5M $1.32M +$13.1K +1.01% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-20
Q4 2018 $5.49M $1.43M +$20.4K +1.45% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-13
Q3 2018 $5.47M $1.34M +$83.3K +6.64% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-20
Q2 2018 $5.39M $1.42M +$41.1K +2.98% Mar 1, 2018 May 31, 2018 10-Q 2019-07-11
Q1 2018 $5.35M $1.31M +$118K +9.89% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-11
Q4 2017 $5.23M $1.41M +$244K +20.9% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-11
Q3 2017 $4.99M $1.25M Jun 1, 2017 Aug 31, 2017 10-K 2018-11-06
Q2 2017 $1.38M +$167K +13.8% Mar 1, 2017 May 31, 2017 10-Q 2018-07-11
Q1 2017 $1.19M Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-12
Q4 2016 $1.16M Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-12
Q2 2016 $1.21M Mar 1, 2016 May 31, 2016 10-Q 2017-07-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.